US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Innovent Biologics Inc.

10.22

+0.04000.39%

Volume:400.00

Turnover:4.08K

Market Cap:17.50B

PE:-1.24K

High:10.22

Open:10.18

Low:10.18

Close:10.18

52wk High:15.12

52wk Low:4.64

Shares:1.71B

Float Shares:1.59B

Volume Ratio:0.44

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0082

EPS(LYR):-0.0080

ROE:8.43%

ROA:2.65%

PB:8.42

PE(LYR):-1,282.95

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

CICC Sticks to Their Buy Rating for Innovent Biologics (IVBXF)

Innovent Biologics, Sanegene Bio announces results on IBI3016

Innovent Biologics announces global strategic partnership with Takeda

Morgan Stanley Sticks to Its Buy Rating for Innovent Biologics (IVBXF)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVBXF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVBXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVBXF\",,,,,undefined,":{"symbol":"IVBXF","market":"US","secType":"STK","nameCN":"Innovent Biologics Inc.","latestPrice":10.22,"timestamp":1770411600000,"preClose":10.18,"halted":0,"volume":400,"delay":15,"changeRate":0.003929273084479462,"floatShares":1592464286,"shares":1712744879,"eps":-0.00822,"marketStatus":"Market Closed","change":0.04,"latestTime":"02-06 16:00:00 EST Delay","open":10.18,"high":10.22,"low":10.18,"amount":4076,"amplitude":0.003929,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.00822,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"PINK LIMITED","adjPreClose":10.18,"volumeRatio":0.4392707718628797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVBXF\",,,,,undefined,":{"symbol":"IVBXF","floatShares":1592464286,"roa":"2.65%","roe":"8.43%","lyrEps":-0.007966,"volumeRatio":0.4392707718628797,"shares":1712744879,"dividePrice":0,"high":10.22,"amplitude":0.003929,"preClose":10.18,"low":10.18,"week52Low":4.64,"pbRate":"8.42","psRate":"10.63","week52High":15.12,"institutionHeld":0,"latestPrice":10.22,"eps":-0.00822,"divideRate":0,"volume":400,"delay":15,"ttmEps":-0.00822,"open":10.18,"prevYearClose":9.75,"prevWeekClose":10.4,"prevMonthClose":10.4,"prevQuarterClose":9.75,"fiveDayClose":10.4,"twentyDayClose":11.55,"sixtyDayClose":10.915},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVBXF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-25","symbol":"IVBXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1661400000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVBXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVBXF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4483,"buy":0.4483,"hold":0.1034,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4483,"analysts":29,"updateTime":1767848400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVBXF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609546057","title":"CICC Sticks to Their Buy Rating for Innovent Biologics (IVBXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609546057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609546057?lang=en_us&edition=fundamental","pubTime":"2026-02-07 13:25","pubTimestamp":1770441945,"startTime":"0","endTime":"0","summary":"CICC analyst maintained a Buy rating on Innovent Biologics yesterday and set a price target of HK$118.30. The company’s shares closed yesterday at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cicc-sticks-to-their-buy-rating-for-innovent-biologics-ivbxf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cicc-sticks-to-their-buy-rating-for-innovent-biologics-ivbxf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVBXF"],"gpt_icon":0},{"id":"2582681814","title":"Innovent Biologics, Sanegene Bio announces results on IBI3016","url":"https://stock-news.laohu8.com/highlight/detail?id=2582681814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582681814?lang=en_us&edition=fundamental","pubTime":"2025-11-10 08:25","pubTimestamp":1762734317,"startTime":"0","endTime":"0","summary":"Innovent Biologics (IVBXF) jointly announced with Sanegene Bio USA that the preliminary results from the first-in-human, FIH, Phase 1 clinical stud...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innovent-biologics-sanegene-bio-announces-results-on-ibi3016-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innovent-biologics-sanegene-bio-announces-results-on-ibi3016-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVBXF"],"gpt_icon":0},{"id":"2577338466","title":"Innovent Biologics announces global strategic partnership with Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2577338466","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577338466?lang=en_us&edition=fundamental","pubTime":"2025-10-22 08:30","pubTimestamp":1761093017,"startTime":"0","endTime":"0","summary":"Innovent Biologics (IVBXF) announced a strategic global collaboration with Takeda (TAK) to advance next-generation IO and ADC cancer therapies, wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innovent-biologics-announces-global-strategic-partnership-with-takeda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innovent-biologics-announces-global-strategic-partnership-with-takeda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVBXF","BK4007","TAK"],"gpt_icon":0},{"id":"2569695733","title":"Morgan Stanley Sticks to Its Buy Rating for Innovent Biologics (IVBXF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569695733","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569695733?lang=en_us&edition=fundamental","pubTime":"2025-09-22 22:35","pubTimestamp":1758551739,"startTime":"0","endTime":"0","summary":"In a report released today, Jack Lin from Morgan Stanley maintained a Buy rating on Innovent Biologics, with a price target of HK$123.00. The compa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-buy-rating-for-innovent-biologics-ivbxf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-buy-rating-for-innovent-biologics-ivbxf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVBXF"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IVBXF\",params:#limit:6,delay:false,,,undefined,":[]}}